In the last decades, due to aging communities and worse risk factor profiles, incidences of
peripheral artery disease (PAD) increased both in western and developing countries and …

Individuals with peripheral arterial disease (PAD) have a significantly elevated risk of
developing major cardiovascular complications, but, until recently, the atherosclerotic …

Aims Peripheral arterial disease (PAD) and coronary artery disease (CAD) are
manifestations of the same underlying condition, atherothrombosis. We compared patients …

Peripheral arterial disease (PAD) is a common, progressive manifestation of
atherothrombotic vascular disease, which should be managed no different to cardiac …

Background and aims It is unclear whether improvements in the detection/treatment of
peripheral artery disease (PAD) affect overall survival and morbidity. We undertook a …

Due to the pathophysiology of atherosclerosis, the management for coronary artery disease
and peripheral arterial disease (PAD) were considered homogenous, with therapies focused …

Peripheral arterial disease (PAD) is a largely unrecognized complication of atherosclerotic
cardiovascular disease (ASCVD). Yet PAD is very much an issue for clinicians in the 21st …

Although peripheral artery disease (PAD) is a manifestation of systemic atherosclerosis, the
heightened cardiovascular risk in these patients has been consistently under-recognized by …

Peripheral arterial disease (PAD) is a progressive disease most often due to atherosclerosis
and characterized by obstruction of arterial blood flow in the lower limbs. The defining …

Peripheral arterial disease (PAD) is a reliable marker of future vascular disease and is a
substantial public health issue. In Europe and North America, 27 million people are …